Evidence map›Paper›PMID 37416738›Full record

ArticleAnnals of gastroenterological surgery2023

The clinical impact of COVID-19 on endoscopic surgery in Japan: Analysis of data from the National Clinical Database.

Hidefumi Shiroshita, Hideki Endo, Masafumi Inomata, Tomonori Akagi, Hiroyuki Yamamoto, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki and 6 more

Abstract read
In one paragraph

Article in Annals of gastroenterological surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hidefumi ShiroshitaAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.ORCID https://orcid.org/0000-0003-2800-8314
Hideki EndoDepartment of Healthcare Quality Assessment, Graduate School of Medicine The University of Tokyo Tokyo Japan.
Masafumi InomataAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.
Tomonori AkagiAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.ORCID https://orcid.org/0000-0002-0722-0343
Hiroyuki YamamotoDepartment of Healthcare Quality Assessment, Graduate School of Medicine The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0003-3337-7595
Shigeki YamaguchiAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.ORCID https://orcid.org/0000-0003-3850-2818
Susumu EguchiAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.ORCID https://orcid.org/0000-0002-7876-0152
Norihito WadaAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.
Yukinori KurokawaAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.ORCID https://orcid.org/0000-0002-2883-0132
Yosuke SekiAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.
Yoshiharu SakaiAcademic Committee of Japan Society for Endoscopic Surgery Tokyo Japan.
Hiroaki MiyataDepartment of Healthcare Quality Assessment, Graduate School of Medicine The University of Tokyo Tokyo Japan.
Yoshihiro KakejiDivision of Gastrointestinal Surgery, Department of Surgery Kobe University Graduate School of Medicine Kobe Hyogo Japan.ORCID https://orcid.org/0000-0002-2727-0241
Yuko KitagawaDepartment of Surgery Keio University School of Medicine Tokyo Japan.
Akinobu TaketomiDepartment of Gastroenterological Surgery I Hokkaido University Graduate School of Medicine Sapporo Hokkaido Japan.
Masaki MoriThe Japan Surgical Society Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study aimed to evaluate the impact of the coronavirus disease (COVID-19) pandemic on elective endoscopic surgeries in Japan using the National Clinical Database. Methods: We retrospectively analyzed the clinicopathological factors and surgical outcomes of laparoscopic cholecystectomy (LC), laparoscopic distal gastrectomy (LDG), and laparoscopic low anterior resection (LLAR) and compared the monthly numbers of each procedure performed in 2020 with those in 2018 and 2019. The degree of infection in prefectures was classified into low and high groups. Results: In 2020, the number of LCs (except for acute cholecystitis) was 76 079 (93.0% of that in 2019), the number of LDGs was 14 271 (85.9% of that in 2019), and the number of LLARs was 19 570 (88.1% of that in 2019). Although the number of robot-assisted LDG and LLAR cases increased in 2020, the growth rate was mild compared with that in 2019. There was little difference in the number of cases in the degree of infection in the prefectures. The numbers of LC, LDG, and LLAR cases decreased from May to June and recovered gradually. In late 2020, the proportion of T4 and N2 cases of gastric cancer and the number of T4 cases of rectal cancer increased compared with those in 2019. There was little difference between the proportions of postoperative complications and mortality in the three procedures between 2019 and 2020. Conclusion: The number of endoscopic surgeries decreased in 2020 as a result of the COVID-19 pandemic. However, the procedures were performed safely in Japan.

Indexed as

COVID‐19endoscopic surgerygastric cancerNational Clinical Databaserectal cancer

Identifiers

PMID37416738
PMCPMC10319603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.